DLA PIPER LLP (US) for NOVARTIS
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Intellectual property protections and enforcement. Biopharmaceutical patent policy.
Foreign entity interest: Novartis International AG, interests are those of the parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| RACHEL PORTMAN | — |
Taxation/Internal Revenue Code TAX
Tax reform and tax policy.
Foreign entity interest: Novartis International AG, interests are those of the parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
Trade (domestic/foreign) TRD
Tariffs and biotechnology issues related to Treasury and competition with China. S. 5316, Biotech Investment National Security Act of 2026 (BINSA Act).
Foreign entity interest: Novartis International AG, interests are those of the parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| RACHEL PORTMAN | — |
Health Issues HCR
Issues relating to drug pricing and drug development policies. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act. H.R. 1672, MINI Act. Most Favored Nation (MFN) policy. Issues related to the 340B program.
Foreign entity interest: Novartis International AG, interests are those of the parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| RACHEL PORTMAN | — |
Medicare/Medicaid MMM
Issues related to rare disease and treatment. Drug and pricing policies. Public policy around patients' access and affordability. Issues related to Medicare Part B and D.
Foreign entity interest: Novartis International AG, interests are those of the parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD BURR | — |
| KARINA LYNCH | — |
| MARGARET MARTIN | — |
| RACHEL PORTMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.